Literature DB >> 18768458

Existing technologies to reduce specific toxicant emissions in cigarette smoke.

R J O'Connor1, P J Hurley.   

Abstract

BACKGROUND: The World Health Organization Tobacco Product Regulation (TobReg) study group has proposed emissions level performance standards for nine toxicants (NNN, NNK, acetaldehyde, acrolein, 1,3-butadiene, CO, BaP, benzene and formaldehyde, all expressed as micrograms per milligram nicotine as measured under the Canadian intensive method) in cigarette smoke for parties to the FCTC in conjunction with regular monitoring of emissions of nine other toxicants of interest, nicotine and nicotine-free dry particulate matter (NFDPM, or "tar").
METHODS: We examined the published literature and publicly available tobacco industry documents to determine the extent to which existing available technologies can be applied to reduce the emissions of the specified toxicants in cigarette smoke.
RESULTS: Agricultural practices (for example, fertilisers, curing), plant characteristics (for example, protein content, nicotine content), tobacco blending (for example, American blend vs Virginia blend) and cigarette design (for example, additives, filters, paper) issues all have roles in the generation and reduction of specific smoke toxicants. The tobacco industry has explored a number of technologies, including selective filtration, changes to curing practices and rod additives to reduce specific toxicants.
CONCLUSIONS: Technologies exist to reduce the toxicants identified by TobReg. The extent to which the industry is able to simultaneously reduce toxicants, however, is unknown.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768458     DOI: 10.1136/tc.2007.023689

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  8 in total

Review 1.  Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.

Authors:  Michael D Johnson; Jodi Schilz; Mirjana V Djordjevic; Jerry R Rice; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

2.  Tobacco-Specific Nitrosamines in the Tobacco and Mainstream Smoke of U.S. Commercial Cigarettes.

Authors:  Selvin H Edwards; Lana M Rossiter; Kenneth M Taylor; Matthew R Holman; Liqin Zhang; Yan S Ding; Clifford H Watson
Journal:  Chem Res Toxicol       Date:  2016-12-21       Impact factor: 3.739

3.  Natural American Spirit launches 'Sky', the brand's first commercial organic cigarette with a charcoal filter.

Authors:  Jennifer Pearson; Daniel P Giovenco; M Jane Lewis; Meghan Moran; Ollie Ganz
Journal:  Tob Control       Date:  2021-09-30       Impact factor: 7.552

4.  Bubbling hookah smoke through heat-solubilized curcumin/turmeric and incorporation of the curry spice as an additive or filter in cigarettes to minimize tobacco smoke-related toxicants.

Authors:  Biji T Kurien; R Hal Scofield
Journal:  Med Hypotheses       Date:  2009-05-10       Impact factor: 1.538

5.  Cigarette Design Features: Effects on Emission Levels, User Perception, and Behavior.

Authors:  Reinskje Talhout; Patricia A Richter; Irina Stepanov; Christina V Watson; Clifford H Watson
Journal:  Tob Regul Sci       Date:  2018-01

Review 6.  Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer.

Authors:  Andrew W Caliri; Stella Tommasi; Ahmad Besaratinia
Journal:  Mutat Res Rev Mutat Res       Date:  2021-01-11       Impact factor: 5.657

Review 7.  Hazardous compounds in tobacco smoke.

Authors:  Reinskje Talhout; Thomas Schulz; Ewa Florek; Jan van Benthem; Piet Wester; Antoon Opperhuizen
Journal:  Int J Environ Res Public Health       Date:  2011-02-23       Impact factor: 3.390

8.  Aldehyde and Volatile Organic Compound Yields in Commercial Cigarette Mainstream Smoke Are Mutually Related and Depend on the Sugar and Humectant Content in Tobacco.

Authors:  Jeroen L A Pennings; Johannes W J M Cremers; Mark J A Becker; Walther N M Klerx; Reinskje Talhout
Journal:  Nicotine Tob Res       Date:  2020-10-08       Impact factor: 4.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.